Brian Dahl

Brian Dahl – ProPharma Group’s Senior Director of Corporate Compliance and Ethics practice. Brian has built corporate compliance programs from the ground up at two pharmaceutical companies – Teva Pharmaceuticals and Takeda Pharmaceuticals – and brings that experience to the service of clients who are in the process of developing, implementing, maintaining, or continuously improving their corporate compliance programs. His in-house experience uniquely qualifies him to understand the realities of both implementing a corporate compliance program in today’s challenging enforcement environment and positioning the compliance function as a valued business partner within a pharmaceutical company. He is a recognized subject matter expert on pharmaceutical corporate compliance and a frequent speaker on the topic. Brian’s career in pharmaceutical corporate compliance began in 2001, at the very beginning of the enforcement era against the pharmaceutical industry. Six months before the government’s seminal settlement with TAP Pharmaceuticals, Brian joined Takeda’s Law Department and took on responsibility for building Takeda’s Corporate Compliance Program. He later created and led Takeda’s Office of Ethics & Compliance to formalize the company’s compliance infrastructure.  Brian received his J.D. from the University of Iowa College of Law and his Master of Health Administration degree from the College of Public Health at the University of Iowa.  

Tags: Expert Biography